Effect of Empagliflozin Versus Placebo on Cardiac Sympathetic Activity in Acute Myocardial Infarction Patients with Type 2 Diabetes Mellitus: Rationale

INTRODUCTION: Protection from lethal ventricular arrhythmias leading to sudden cardiac death is one of the most important problems after myocardial infarction. Cardiac sympathetic hyperactivity is related to poor prognosis and fatal arrhythmias and can be non-invasively assessed with heart rate vari...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubota, Yoshiaki, Yamamoto, Takeshi, Tara, Shuhei, Tokita, Yukichi, Yodogawa, Kenji, Iwasaki, Yuki, Takano, Hitoshi, Tsukada, Yayoi, Asai, Kuniya, Miyamoto, Masaaki, Miyauchi, Yasushi, Kodani, Eitaro, Sato, Naoki, Tanabe, Jun, Shimizu, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167287/
https://www.ncbi.nlm.nih.gov/pubmed/30097993
http://dx.doi.org/10.1007/s13300-018-0480-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167287/
https://www.ncbi.nlm.nih.gov/pubmed/30097993
http://dx.doi.org/10.1007/s13300-018-0480-7

Ejemplares similares